3 ms·
In France at least I believe there was (and probably still is) also a distribution problem. Also health authorities flip-flopping on the benefits and side effe
by cm2187 6y ago
In France at least I believe there was (and probably still is) also a distribution problem.
Also health authorities flip-flopping on the benefits and side effects is disastrous from an adoption point of view. First it is not efficient for people over 65, then it is, then it will only be distributed to people over 50, then it is dangerous, then it is not dangerous anymore. You couldn't manufacture reluctance to getting vaccinated more if you wanted to.
- jeromenerf 6y agoDistribution is OK. The main problem is the availability of the approved vaccine doses. AZ vaccine is easy to move around, at near 0°C. As for the flip-flopping, it’s the usual media game. High public expectations, low delivery. What is really annoying is that french pharma has not been able to invent a vaccine or at least able to manufacture someone else’s.